Related Experiment Video
Updated: Jan 20, 2026

Studying Wnt Signaling During Patterning of Conducting Airways
Published on: October 16, 2016
Wnt Signaling in Cancer: Not a Binary ON:OFF Switch
Dustin J Flanagan1, Elizabeth Vincan2,3, Toby J Phesse4,5
1Cancer Research UK Beatson Institute, Glasgow, United Kingdom.
Abstract:
In the March 1 issue of Cancer Research, we identified the Wnt receptor Fzd7 as an attractive therapeutic target for the treatment of gastric cancer. In summary, we showed that pharmacological inhibition of Wnt receptors, or genetic deletion of Fzd7, blocks the initiation and growth of gastric tumors. Inhibiting Fzd receptors, specifically Fzd7, inhibits the growth of gastric cancer cells even in the presence of adenomatous polyposis coli (Apc) mutation. Apc is located in the cytoplasm downstream of Fzd7 in the Wnt signaling cascade and APC mutations activate Wnt/β-catenin signaling, therefore, this result seems counterintuitive. Here, we analyze this result in greater detail in the context of current knowledge of Wnt signaling and discuss the wider implications of this aspect of Wnt signaling in other cancers.
Insights
The Wnt receptor Fzd7 is a promising target for gastric cancer therapy. Inhibiting Fzd7 blocks tumor growth, even with mutations in adenomatous polyposis coli (APC).
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The Wnt signaling pathway is crucial in cancer development, particularly in gastric cancer.
- Fzd7 is a Wnt receptor implicated in various cancers.
- Adenomatous polyposis coli (APC) mutations activate Wnt/β-catenin signaling, a common event in gastric cancer.
Purpose of the Study:
- To investigate Fzd7 as a therapeutic target for gastric cancer.
- To analyze the effect of Fzd7 inhibition on gastric tumor initiation and growth.
- To explore the role of Fzd7 in gastric cancer with APC mutations.
Main Methods:
- Pharmacological inhibition of Wnt receptors.
- Genetic deletion of the Fzd7 gene.
- Analysis of Wnt signaling cascade components.
- Cell culture and tumor xenograft models.
Main Results:
- Pharmacological inhibition or genetic deletion of Fzd7 effectively blocked gastric tumor initiation and growth.
- Fzd7 inhibition suppressed gastric cancer cell growth, irrespective of APC mutation status.
- This finding appears counterintuitive given APC's role downstream in Wnt signaling.
Conclusions:
- Fzd7 is a viable therapeutic target for gastric cancer treatment.
- Targeting Fzd7 offers a potential strategy for overcoming resistance associated with APC mutations.
- Further investigation into Wnt signaling dynamics in cancer is warranted.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Binary Fission
Binary Fission
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Switching of BJT
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...

